inn

(redirected from Bortezomib)
Also found in: Dictionary, Thesaurus, Medical, Legal, Wikipedia.

Inn

(ĭn), river, c.320 mi (515 km) long, rising near the Lake of Sils, SE Switzerland. It flows NE through the Engadine valley, then through W Austria, past Innsbruck and Solbad Hall (the head of navigation), and into S central Germany. The Inn forms part of the German–Austrian border before entering the Danube River at Passau. There are more than 20 hydroelectric power plants on the river's swift-flowing stream.

inn,

in Great Britain, any hotel, public house, tavern, or coffeehouse where lodging is provided. In American usage, the inn is generally a small rural lodging house for transients. Among the earliest public houses were empty huts placed at caravan stops in the Middle East for the shelter of traders and travelers. To pilgrims, temples and religious houses gave rest and refreshment—a custom that still lingers in some Alpine hospices. The Romans maintained post stations on their great highways for the use of messengers of state and those especially privileged. For the accommodation of ordinary transients, stabularia were kept for man and beast. In the Middle Ages hospitality was observed as one of the Christian duties by the establishment of hospices in cities and by the entertainment of travelers at monasteries. Inns kept for profit appeared in Europe about the 15th cent. and gained a reputable standing in England, often being named for the powerful family on whose holdings they were established. They were usually built around a courtyard, approached by a wide, covered entry. In America, colonial inns similar to the English hostelries sprang up along the great turnpikes.

Bibliography

See W. C. Firebaugh, Inns of the Middle Ages (1924); H. A. Monckton, A History of the English Public House (1969).

Inn

A place which provides eating and drinking, but not lodging, for the public; a tavern.

inn

1. A place which provides eating and drinking, but no lodging, for the public; a tavern.
2. A hotel.
3. A student hostel or residence.
4. A hospice.

inn

1. a pub or small hotel providing food and accommodation
2. (formerly, in England) a college or hall of residence for students, esp of law, now only in the names of such institutions as the Inns of Court

Inn

a river in central Europe, rising in Switzerland in Graub?nden and flowing northeast through Austria and Bavaria to join the River Danube at Passau: forms part of the border between Austria and Germany. Length: 514 km (319 miles)

INN

(InterNet News) A complete Usenet system written by Rich Salz that includes an NNTP server and components for newsreading. INN is available from the Internet Systems Consortium (www.isc.org). See Usenet and ISC.
References in periodicals archive ?
In this head-to-head comparison, carfilzomib plus dexamethasone resulted in a twofold decrease in the risk of progression or death, compared with bortezomib plus dexamethasone, a result that was consistent regardless of age or prior bortezomib exposure," said study co-author and investigator, Meletios A.
8 months in participants treated with bortezomib and dexamethasone alone.
Subcutaneous bortezomib also offers an alternative choice for patients with poor venous accessibility or those at risk of, or with pre-existing, peripheral neuropathy, for whom bortezomib IV may previously not have been an option.
In patients who received the bortezomib regimen the long-term OS benefit was observed across multiple patient subgroups, including those aged ≥ 75 years (median 50.
panobinostat, previously known as LBH589) in combination with bortezomib[*] and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma who had received two or more prior regimens, including bortezomib and an immunomodulatory agent (IMiD)[sup.
Based on more than 9,000 elderly MM patients, there was a lower prevalence of second malignancies among patients exposed to bortezomib (1.
85 percent of patients had prior bortezomib exposure and18 percent were bortezomib refractory, 92 percent had previous lenalidomide exposure, 48 percent had prior thalidomide exposure and 12 percent had prior carfilzomib exposure.
May 31, 2015 /PRNewswire/ -- AbbVie (NYSE:ABBV), a global biopharmaceutical company, today announced that results from a Phase 1b trial of investigational venetoclax, a novel inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, in combination with bortezomib and dexamethasone, showed an 83 percent overall response rate (n=5/6) in bortezomib-naive patients with relapsed/refractory (R/R) multiple myeloma, including two patients who achieved complete responses.
Phase 3b UPFRONT Study: Safety and Efficacy of Weekly Bortezomib Maintenance Therapy After Bortezomib-Based Induction Regimens in Elderly, Newly Diagnosed Multiple Myeloma Patients.
In some of the multiple myeloma (MM) cell line models, A2A and beta-2 adrenergic receptor agonists synergized with melphalan, lenalidomide, bortezomib and doxorubicin.
was approved in combination with bortezomib and dexamethasone for the treatment of patients with multiple myeloma who have received at least two prior regimens, including bortezomib and an immunomodulatory agent.
Contract award: supply of bortezomib, lenalidomide, nilotinib and sorafenib, negotiated procedure without call for competition